Yahoo! News - Under Pressure Glaxo Publishes Paxil Data
Search the web
Yahoo! NewsSign In
New User? Sign Up
Welcome, Guest Personalize News Home Page   -   Sign In
Yahoo! News   Mon, Jun 21, 2004
Search for    Advanced
News Home
Top Stories
U.S. National
Business
World
Entertainment
Sports
Technology
Politics
Science
Health
   Weight Loss
   Sexual Health
   Medications/Drugs
   Parenting/Kids
   Seniors/Aging
   Diseases/Conditions
Most Popular
Oddly Enough
Op/Ed
Local
Comics
News Photos
Most Popular
Weather
Audio/Video
Full Coverage

News Resources
Providers
· Reuters
· AP
· HealthDay
· ACS News Today
· AFP
· CP
·News Alerts
 News via RSS
 
Health - Reuters
Reuters
Under Pressure Glaxo Publishes Paxil Data

Wed Jun 16, 3:09 PM ET
Add Health - Reuters to My Yahoo!

NEW YORK (Reuters) - GlaxoSmithKline Plc (GSK.L), responding to a lawsuit claiming it suppressed negative data about its antidepressant Paxil, published results of trials showing the drug is broadly ineffective in children and adolescents and could increase risks of suicidal behavior.

Related Quotes
GSK
DJIA
NASDAQ
^SPC
42.88
10422.93
1991.56
1136.35
-0.02
+6.52
+4.83
+1.33

delayed 20 mins - disclaimer
Quote Data provided by Reuters
Yahoo! Health
Have questions about your health?
Find answers here.

 

The British drugmaker released data from nine pediatric trials on its Web Site after New York Attorney General Eliot Spitzer filed suit two weeks ago accusing Glaxo of fraudulently suppressing the information.

Glaxo has denied the allegations, saying it publicized the results either in medical journals or at scientific meetings. The data released by Glaxo earlier this week showed Paxil to be mostly ineffective in treating youngsters.

In a letter to physicians published before Spitzer's lawsuit, the company said that while no patients committed suicide, there was a difference between patients on Paxil and those on placebo in suicidal thinking and suicide attempts.

The incidence of negative events possibly related to suicidal behavior was 2.4 percent in patients on Paxil, compared to 1.1 percent in patients on the placebo, the company said.

In a 30-day follow-up trial, that rate increased to 3.4 percent for patients treated with Paxil compared to 1.2 percent in the placebo group.

Spitzer's suit claims Glaxo published only one trial, which had mixed results, and suppressed the results of the other studies suggesting a possible increased risk of suicidal thinking and acts.

Paxil is approved in the United States only for adults, but doctors are allowed to prescribe it for children on an "off-label" basis.


Story Tools
Mail to Friend  Email Story
Message Boards   Post/Read Msgs
Printer Version   Print Story  
Ratings: Would you recommend this story?
Not at all 1 - 2 - 3 - 4 - 5 Highly
Tools Sponsored by: HP



Next Story: Mental Impairment Common with Breast Cancer (Reuters)

More Health Stories
· Study: Few Women Get Annual Mammograms   (AP)
· Health Tip: Baby's First Solids  (HealthDay)
· Seeking Solutions to 'Chemo-Brain'  (American Cancer Society)
· UN envoy calls on Namibia to step up AIDS fight  (AFP)
· High Court Limits Patient Suits Vs HMOs  (Reuters)

ADVERTISEMENT


Online Graduate Degrees in Health
Online Graduate Degrees in Health
Browse All Health Programs
from Yahoo! Education

Copyright 2004 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Copyright © 2004 Yahoo! Inc. All rights reserved.
Questions or Comments
Privacy Policy -Terms of Service - Copyright Policy - Ad Feedback